Ming-Jie Li

Dr. Ming-Jie Li

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2023 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
HDHao Dong
Hao Dong
SYShi-Bai Yan
Shi-Bai Yan
GLGuo-Sheng Li
Guo-Sheng Li
ZHZhi-Guang Huang
Zhi-Guang Huang
DLDong-Ming Li
Dong-Ming Li
MLMing-Jie Li
Ming-Jie Li
Background: To investigate the potential role of immune-related genes (IRGs) and immune cells in myocardial infarction (MI) and establish a nomogram model for diagnosing myocardial infarction. Methods: Raw and processed gene expression profiling datasets were archived from the Gene Expression Omnibus (GEO) database. Differentially expressed immune-related genes (DIRGs), which were screened out by four machine learning algorithms-partial least squares (PLS), random forest model (RF), k-nearest neighbor (KNN), and support vector machine model (SVM) were used in the diagnosis of MI. Results: The six key DIRGs (PTGER2, LGR6, IL17B, IL13RA1, CCL4, and ADM) were identified by the intersection of the minimal root mean square error (RMSE) of four machine learning algorithms, which were screened out to establish the nomogram model to predict the incidence of MI by using the rms package. The nomogram model exhibited the highest predictive accuracy and better potential clinical utility. The relative distribution of 22 types of immune cells was evaluated using cell type identification, which was done by estimating relative subsets of RNA transcripts (CIBERSORT) algorithm. The distribution of four types of immune cells, such as plasma cells, T cells follicular helper, Mast cells resting, and neutrophils, was significantly upregulated in MI, while five types of immune cell dispersion, T cells CD4 naive, macrophages M1, macrophages M2, dendritic cells resting, and mast cells activated in MI patients, were significantly downregulated in MI. Conclusion: This study demonstrated that IRGs were correlated with MI, suggesting that immune cells may be potential therapeutic targets of immunotherapy in MI.

19 May 2025 in Extracellular Vesicles and Circulating Nucleic Acids
Verified
Journal Article
Open access
PDF file
HWHai-Quan Wang
Hai-Quan Wang
LZLu Zhang
Lu Zhang
MLMing-Jie Li
Ming-Jie Li
RHRongquan He
Rongquan He
DQDi-Yuan Qin
Di-Yuan Qin
GCGang Chen
Gang Chen
Aim: The domain of exosomal circRNAs has seen rapid growth over the past few years, yet a thorough synthesis of the scholarly contributions has been lacking. This study employs bibliometric analysis to uncover the focal points and trends in exosomal circRNA research. Methods: We selected articles on exosomal circRNAs from the Web of Science Core Collection (WoSCC) and deployed VOSviewer for co-authorship and co-occurrence analysis. CiteSpace was tapped to calculate citation bursts for documents and keywords, generating a time-zone map. Additionally, the bibliometrix R package was employed to identify locally cited references and construct thematic maps and trend topics. Results: The exosomal circRNA research field has produced 767 articles over the past decade. China and Fudan University lead in publication counts, ranking first among countries and institutions, respectively. The journal with the highest number of publications and citations is Molecular Cancer . Zhang Wei and Li Yan are the top contributors and the most co-cited authors, respectively. Analysis of the results suggests that research related to the tumor microenvironment (TAM) may be a recent research hotspot. Among the latest keywords, terms such as microenvironment, macrophage, mesenchymal stem cells, and ceRNA appear frequently. The keyword with the most recent citation burst is ceRNA. The latest trend topic is the macrophage, and mesenchymal stem cell is identified as an emerging theme. Conclusion: This study elucidates the hotspots and trends in exosomal circRNA research through bibliometric analysis. Themes related to the TAM, especially directions involving macrophages, fibroblasts, and mesenchymal stem cells, will likely open a new chapter in exosomal circRNA research.

1 February 2026 in Journal of Inflammation Research
Verified
Journal Article
Open access
KWKunjun Wu
Kunjun Wu
SHShipei He
Shipei He
YSYuyan Shen
Yuyan Shen
JLJiandi Li
Jiandi Li
BLBin Li
Bin Li
MLMing-Jie Li
Ming-Jie Li
Background: Atherosclerosis (AS) is the leading cause of death from cardiovascular disease worldwide, involving complex inflammatory, molecular and cellular pathways as well as intercellular cross-talk. CircRNAs are highly stable, circular non-coding RNAs that function by acting as miRNA sponges, regulating transcription, and influencing protein translation. In AS research, CircRNAs have turned the spotlight onto a promising new target with significant therapeutic potential. This study aimed to elucidate academic landscape, reveal active topics and future research focus of CircRNAs in AS research. Methods: Publications on CircRNAs in AS research were retrieved from Web of Science Core Collection (WoSCC). The bibliometric tools, including R, VOSviewer and Citespace, were used to conduct a scientometric analysis of 225 relevant studies. Results: This study identifies China as the primary research nations in the field of CircRNAs in AS research. However, attention must still be paid to the striking imbalance between productivity and deserved impact. The majority of current research is conducted using in vitro models. However, in vivo experiments are urgently needed to provide additional evidence for the inconclusive results obtained in vitro. The lipid infiltration theory, particularly the role of CircRNAs in regulating macrophage cholesterol efflux, has become a new research entry point for the treatment of AS. In addition, this study also identified pyroptosis and exosomes as future research focus in the field of CircRNAs in AS research. Conclusion: This bibliometric analysis synthesises the extensive evidence on CircRNAs in AS research and provides insights to guide future scientific work in this field.

22 August 2026 in Hereditas
Verified
Journal Article
Open access
PDF file
KWKe-Jun Wu
Ke-Jun Wu
LWLei Wang
Lei Wang
YZYan-Ting Zhan
Yan-Ting Zhan
YTYu-Lu Tang
Yu-Lu Tang
MLMing-Jie Li
Ming-Jie Li
SCSi-Yan Chen
Si-Yan Chen
Background: Cholangiocarcinoma (CHOL) is a highly heterogeneous and aggressive malignancy that is frequently diagnosed at an advanced stage because of the lack of early biomarkers, resulting in a poor prognosis. Although ANAPC1 overexpression has been reported in other cancers, its role and regulatory mechanisms in CHOL remain insufficiently characterized. Objectives: To characterize ANAPC1 expression in CHOL, identify candidate upstream transcriptional regulators, and elucidate the associated functional programs and pathways. Methods: Multi-omics profiling was integrated with in-house immunohistochemical validation. Differential expression analyses, CRISPR-based functional screening, transcription-factor prioritization, ChIP-seq with epigenomic annotation, gene set enrichment analysis, spatial transcriptomics, and single-cell RNA-seq were conducted to investigate ANAPC1-associated regulatory mechanisms in CHOL.Structural modeling of predicted TEAD4–DNA complexes was additionally performed to assess the structural compatibility between TEAD4 and candidate ANAPC1 promoter motifs. Results: ANAPC1 was significantly overexpressed in CHOL at both the transcriptomic level (436 CHOL vs. 213 non-CHOL samples) and the protein level (66 CHOL vs. 99 non-CHOL tissues), with spatial enrichment in cholangiocytes. Public CRISPR dependency screening indicated that ANAPC1 loss was associated with reduced cellular fitness in several CHOL cell lines, including HUCCT1. Integrative analyses identified TEAD4 as a candidate upstream regulator of ANAPC1, and TEAD4 was upregulated in CHOL. Public ChIP-seq and epigenomic datasets across multiple cell lines, including HUCCT1, HepG2, BE2-C, and MDA-MB-231, suggested TEAD4 occupancy at the ANAPC1 locus, together with active chromatin features such as H3K27ac signals near the promoter region. Across several bulk transcriptomic datasets, TEAD4 and ANAPC1 showed positive expression associations of varying magnitude, whereas spatial transcriptomics indicated partially overlapping regional enrichment within malignant areas.Protein–DNA complex modeling of a predicted candidate TEAD4–ANAPC1 promoter DNA complex yielded an ipTM score of 0.71 and a pTM score of 0.62 for the top-ranked candidate promoter motif. GSEA identified positive enrichment of proliferation- and RNA-processing-related pathways and negative enrichment of several immune-related pathways within the ANAPC1-correlated transcriptomic profile. Single-cell analysis further localized ANAPC1 expression mainly to cholangiocytes and identified a statistically significant but extremely weak cell-level correlation with TEAD4. Conclusions: These findings support the hypothesis of a putative TEAD4–ANAPC1 regulatory relationship in CHOL based on integrative epigenomic, transcriptomic, spatial, and structural analyses. Direct experimental validation is required to determine whether TEAD4 functionally regulates ANAPC1 transcription in cholangiocarcinoma.